The Scottish scientist in the frontline of the battle against the deadly coronavirus is warning the need for a vaccine is even more critical with more than 31,000 confirmed cases and around 630 deaths.
Dr Kate Broderick, is working round the clock with her team of researchers at the pharmaceutical company Inovio in San Diego to develop a jab in just six months.
The 42-year-old, who is originally from Dunfermline, and has been living in California for 20 years, says the aim is to make a vaccine faster than theyve made any other in our history.
Broderick has helped create successful vaccines for ebola, zika, lassa fever and Mers (Middle East Respiratory Syndrome) moving from Glasgow to develop her work in molecular genetics.
She first read about the coronavirus outbreak on Hogmanay and saw that the World Health Organisation had reported a couple of cases.
From there the Chinese authorities published the DNA sequence online which was the trigger for Broderick and her team to start working on a new vaccine.
She said: Seeing it online was like 100 per cent confirmation that this was a new virus but even before that from the disease symptoms it wasnt fitting into any particular box.
So, we already suspected that this was something new.
We downloaded the sequences and the first stage of our development is done on a computer which is why our technology at Novio allows us to go so far.
We ran the sequences through a computer algorithm and three hours later we actually had a full design for the vaccine and the next day we were able to put that into manufacturing.
She added: Its definitely 100 per cent a race against the clock were working here 24/7 and thats not an exaggeration to get this thing out.
What were trying to do here is make a vaccine faster than weve ever made any other vaccine in our history.
Our fastest in the past was seven months from sequence to patient and that was for the Zika outbreak where kids were being born with these terrible neurological deficits and we really sprang into action there.
We got the viral sequence and we got it tested in humans within seven months and we were so proud of that and here for the novel coronavirus were trying to do it significantly faster than that.
We need international support and I think were seeing that in the scientific community.
Theres a lot of organisations working together but its absolutely a race against time.
The UK government announced earlier this week that it has pledged 20 million to develop new vaccines to combat the worlds deadliest diseases, amid concerns over the novel coronavirus, 2019-nCoV.
Dr Broderick welcomed the funding which will go to the Coalition for Epidemic Preparedness Innovations (CEPI), originally formed in response to the Ebola epidemic in West Africa.
She added: Thats what we need now funding to support this work.
We have to follow all the established protocols and work with the authorities thats absolutely critical.
So, all we would do first is a phase one clinical trial which we plan to do early summer.
Thats testing it on completely healthy people just to get a read-out of the fact the vaccine is safe and its doing what we hope its going to do.
We hope to roll that out in the US in the early summer and well also be working with our colleagues in China to do similar kinds of trials there with an eye to discussing with the Chinese authorities to get the vaccine out to people who need it as soon as its available.
Dr Broderick has retained her Scottish accent having gone to St Columbas High School in Dunfermline before studying genetics at the University of Glasgow, where she also completed her PhD.
Her father was a physicist, her mother a therapist, one of her sisters is a nurse and the other is a social worker.
She met her husband, Steve, in California, and 20 years on is still there. She has two children, Rory, aged eight, and four-year-old Isla.
She said: Every single day almost someone will ask me if Im here on vacation and Ill say no Ive been here for 20 years.
I come back to Scotland at least once a year and my whole family are still in Scotland and I feel very, very Scottish.
Im proud of my adopted home in California but I very much consider myself Scottish.
Here is the original post:
Coronavirus: Meet the Scottish doctor working to create life-saving vaccine - Scotland on Sunday
- Heredity - DNA, Genes, Inheritance | Britannica - January 6th, 2025
- Comparing Genetics and Molecular Genetics: What's the Difference? - December 19th, 2024
- Standards and guidelines for the interpretation of sequence ... - PubMed - December 19th, 2024
- Chapter 12: Techniques of Molecular Genetics - Biology LibreTexts - December 19th, 2024
- 8.S: Techniques of Molecular Genetics (Summary) - December 19th, 2024
- Master of Science Computational Biology and Quantitative Genetics - December 19th, 2024
- Pitt Researchers Lead Group that Calls for Global Discussion About Possible Risks from Mirror Bacteria - Pitt Health Sciences - December 19th, 2024
- Molecular Genetics Testing - StatPearls - NCBI Bookshelf - November 16th, 2024
- Working with Molecular Genetics (Hardison) - Biology LibreTexts - November 16th, 2024
- Molecular Underpinnings of Genetic and Rare Diseases: From ... - Frontiers - November 16th, 2024
- The molecular genetics of schizophrenia: New findings promise new insights. - November 16th, 2024
- 8: Techniques of Molecular Genetics - Biology LibreTexts - September 4th, 2024
- 1.5: Molecular Genetics - Biology LibreTexts - September 4th, 2024
- Molecular genetics made simple - PMC - National Center for ... - September 4th, 2024
- 4 Introduction to Molecular Genetics - University of Minnesota Twin Cities - September 4th, 2024
- Molecular genetics - Definition and Examples - Biology Online - September 4th, 2024
- A Detailed Look at the Science of Molecular Genetics - KnowYourDNA - September 4th, 2024
- Molecular Genetics | NHLBI, NIH - September 4th, 2024
- Molecular biology - Wikipedia - September 4th, 2024
- Genetics, Molecular & Cellular Biology Admissions - September 4th, 2024
- Researchers map 50,000 of DNAs mysterious knots in the human genome - EurekAlert - September 4th, 2024
- Artificial selection of mutations in two nearby genes gave rise to shattering resistance in soybean - Nature.com - September 4th, 2024
- Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany - Marketscreener.com - April 7th, 2023
- Molecular Genetics and Metabolism | Journal - ScienceDirect - December 11th, 2022
- People don't mate randomly but the flawed assumption that they do is an essential part of many studies linking genes to diseases and traits - The... - November 25th, 2022
- Molecular and Cell Biology and Genetics - Master of Science / PhD ... - October 7th, 2022
- NIPD Genetics: Leading Genetic Testing Company - October 7th, 2022
- Skeletal Biology and Regeneration Students Recognized For Research Excellence - UConn Today - University of Connecticut - October 7th, 2022
- Mary Munson elected fellow of the American Society for Cell Biology - UMass Medical School - October 7th, 2022
- Every Body's Talking at Them: an Interview with Jon Lieff - CounterPunch - October 7th, 2022
- TriBeta invites students to explore opportunities to work with faculty at research fair on Oct. 11 - Ohio University - October 7th, 2022
- Genetics: the Vatican Does Not Intend to Be Behind the Times - FSSPX.News - October 7th, 2022
- Yield10 Bioscience Appoints Willie Loh, Ph.D., to the Board of Directors - citybiz - October 7th, 2022
- Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry - Nature.com - October 7th, 2022
- Sigyn Therapeutics Strengthens Board of Directors With the Appointments of Richa Nand, Jim Dorst and Christopher Wetzel - Yahoo Finance - October 7th, 2022
- UTHSC Researcher Co-Leads Study of Genes that Modulate Aging, Lifespan - UTHSC News - UTHSC News - October 7th, 2022
- GATC Health Investor Conference to Feature First Public Demonstration of Its AI Platform's Drug Discovery Capabilities - PR Newswire - October 7th, 2022
- Three Professors Conferred Tenure and Eleven Promoted - Wesleyan Argus - October 7th, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 7th, 2022
- Dalhousie to present exhibition celebrating Gerhard Herzberg and his legacy - Dal News - October 7th, 2022
- Why Some People Should Rethink Their Morning Cup Of Coffee - Health Digest - October 7th, 2022
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 7th, 2022
- UofL researchers lead the call to increase genetic diversity in immunogenomics - uoflnews.com - July 6th, 2021
- In Brief This Week: Foundation Medicine, Myriad Genetics, Genetron Health, and More - GenomeWeb - July 6th, 2021
- More filling? Tastes great? How flies, and maybe people, choose their food - Yale News - July 6th, 2021
- Genetic mapping of subsets of patients with fragile X syndro | TACG - Dove Medical Press - July 6th, 2021
- What is The Babydust Method? Danielle Lloyd swears method helped her conceive girl - The Mirror - July 6th, 2021
- Datar Cancer Genetics joins hands with US based Iylon Precision Oncology to offer personalized Precision Oncology cancer treatment solutions - PR Web - July 6th, 2021
- Mapping a pathway to competitive production - hortidaily.com - hortidaily.com - July 6th, 2021
- Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. - Physician's Weekly - July 6th, 2021
- Global Genomics Market | Rising Incidence of Chronic and Genetic Diseases are Key Factors to Grow Market During 2021-2029 | 23andMe, Agilent... - July 6th, 2021
- The Babydust Method Danielle Lloyd used to conceive a girl after four sons and how it works - RSVP Live - July 6th, 2021
- In the beginning science and faith - The Irish Times - June 24th, 2021
- Ancient Maya Maintained Native Tropical Forest Plants around Their Water Reservoirs | Archaeology - Sci-News.com - June 24th, 2021
- Local foundation awards $1.25 million to MIND Institute to study rare genetic condition - UC Davis Health - June 24th, 2021
- Xlife Sciences AG: Collaboration with the University of Marburg - Yahoo Finance - June 24th, 2021
- Genetics diagnostics in India is on the verge of transformation: Neeraj Gupta, Founder and CEO of Genes2me - The Financial Express - June 24th, 2021
- Precision Medicine: Improving Health With Personalized Solutions - BioSpace - June 24th, 2021
- Half of Portland areas 22 top National Merit winners hail from just 2 schools - OregonLive - June 24th, 2021
- Investing in stem cells, the building blocks of the body - MoneyWeek - June 24th, 2021
- New study finds low levels of a sugar metabolite associates with disability and neurodegeneration in multiple sclerosis - Newswise - May 14th, 2021
- Cernadas-Martn Is a Champion for Marine and Human Diversity | | SBU News - Stony Brook News - May 14th, 2021
- Four Penn Faculty: Election to the National Academy of Sciences - UPENN Almanac - May 14th, 2021
- Is there a difference between a gene-edited organism and a 'GMO'? The question has important implications for regulation - Genetic Literacy Project - May 14th, 2021
- 5 Students Inducted Into American Society for Biochemistry and Molecular Biology Honor Society - Wesleyan Connection - May 14th, 2021
- The Science of Aliens, Part 2: What Kind of Genetic Code Would Extraterrestrials Have? - Air & Space Magazine - May 14th, 2021
- UT Austin Faculty Member Receives 2021 Piper Professor Award - Office of the Executive Vice President and Provost - UT News | The University of Texas... - May 14th, 2021
- Distinguished University of Birmingham plant scientist elected to the Royal Society - University of Birmingham - May 14th, 2021
- Double Hoo Research: Undergrads and Grads Team Up to Create Knowledge - University of Virginia - May 14th, 2021
- Global Genetic Testing Market Top Countries Analysis and Manufacturers With Impact of COVID-19 | 2021-2028 Detail Analysis focusing on Application,... - May 14th, 2021
- Morag Park named to the Order of Quebec - McGill Reporter - McGill Reporter - May 14th, 2021
- Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A - BioSpace - May 14th, 2021
- The Royal Society announces election of new Fellows 2021 - Cambridge Network - May 14th, 2021
- Researchers Decode the "Language" of Immune Cells - Technology Networks - May 14th, 2021
- RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map -... - May 14th, 2021
- Mice Sperm Sabotage Other Swimmers With Poison | Smart News - Smithsonian Magazine - February 14th, 2021
- Study Identifies Never-Before-Seen Dual Function in Enzyme Critical for Cancer Growth - Newswise - February 14th, 2021
- Devious sperm 'poison' their rivals, forcing them to swim in circles until they die - Livescience.com - February 14th, 2021
- More needs to be done to find and fight COVID-19 variants, says Colorado researcher - FOX 31 Denver - February 14th, 2021
- Selfish sperm genes 'poison' the competition for the win - Big Think - February 14th, 2021